Targeted dosing to treat pediatric inflammatory bowel disease is challenging because dosing guidelines are based on data gathered from adult subjects of clinical trials. Patients’ families and health care organizations also incur high costs and must try to balance potential benefits against risks of ongoing monitoring.
AMA J Ethics. 2018;20(9):E841-848. doi:
10.1001/amajethics.2018.841.
Robert Ledbetter and Dr Buddy Marterre join Ethics Talk to discuss their article: “Where’s the Value in Preoperative Covenants Between Surgeons and Patients?”
When responding to an ad for a job caring for patient-detainees along the US southern border, applicants should anticipate the need to navigate dual loyalties.
AMA J Ethics. 2021;23(1):E12-17. doi:
10.1001/amajethics.2021.12.